Culture

01/11/25

Semper Maior: Pumping up the candor

Biotech

Culture

Finance

12/20/24

What you were reading — Rapport’s top stories of 2024

Biotech

Culture

Finance

Policy

Science

Planetary

12/18/24

ESPN always shows the struggle; this time, it’s mine

Biotech

Culture

Science

12/06/24

“Keep it under 20”

Biotech

Culture

11/20/24

Utilizing investors on and off your Board

Biotech

Culture

10/18/24

How do you resolve conflict among board members and executives?

Biotech

Culture

09/30/24

What makes a good board chair?

Biotech

Culture

08/16/24

How Jnana picked PKU

Biotech

Culture

Science

06/20/24

When it comes to global drug sales, all revenue is not created equal

Biotech

Culture

Policy

04/23/24

Eroding tolerance: A wonder drug shows us the drug industry’s fundamental failure to communicate

Biotech

Culture

Policy

02/29/24

Money talks: Your biotech compensation questions, answered

Biotech

Culture

Finance

02/18/24

New DTC Marketing: Bringing our true customers along on our quest

Biotech

Culture

12/19/23

Rapport’s most popular pieces of 2023

Biotech

Culture

12/15/23

Your New Year’s Resolution: Set useful corporate goals in 2024

Biotech

Culture

12/01/23

Planetary Health: people, planet, profit

Culture

Planetary

05/23/23

How to navigate and de-risk your next career move in biotech: pros, cons, and tips for every stage

Culture

01/20/23

So you want to be a TechAtlas intern…

Biotech

Culture

01/13/23

Is ChatGPT smarter than Congress?

Biotech

Culture

12/21/22

What you were reading — RApport’s 2022 Top Ten

Culture

Finance

Policy

Science

11/22/22

I walked 100 miles for this term sheet

Biotech

Culture

Finance